Skip to main content
Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,680.00
+615.00 (29.78%)
At close: Jun 26, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Pharmaceutical
100.00M
Log In
Log In
Log In
Log In
Technology Transfer
-
Log In
Log In
Log In
Log In
Technology Transfer Growth
-
Log In
Log In
Log In
Log In
Transfer to Test Substance
-
Log In
Log In
Log In
Log In
Transfer to Test Substance Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
South Korea
100.00M
Log In
Log In
Log In
Log In
South Korea Growth
-96.69%
Log In
Log In
Log In
Log In
Europe
-
Log In
Log In
Log In
Log In
Europe Growth
-
Log In
Log In
Log In
Log In